blinatumomab
astellas pharmaceuticals,amgen
['leusm', 'blinatumomab']
congress #eha22| presented phase iii data supporting 1 cycle of blinatumomab vs chemotherapy prior to allohsct in children with high-risk 1st-relapse b-all. n=111, at 4yr efs=59%, os=77% &amp; improved mrd clearance, all independent of bl mrd #allsm #leusm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm